Portfolio company
Vivifi Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Vivifi Medical develops a laparoscopic surgical device for clinicians to treat benign prostatic hyperplasia and male infertility by reconnecting blood vessels.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alpfa Medical
The company develops pulsed field ablation systems to treat benign prostatic hyperplasia in men.
OctoVascular
OctoVascular develops automated vessel connection technology for surgeons to perform minimally invasive coronary artery bypass surgery.
ProVerum Medical
The company develops a minimally invasive urethral stent system to treat benign prostatic hyperplasia for urologists and patients.
NeoSurgical
The company develops laparoscopic instruments for surgeons to close port site incisions after abdominal surgery.
ProVerum
This company develops minimally invasive nitinol stents to treat benign prostatic hyperplasia in male patients.
Allotrope Medical
This company develops a smooth muscle stimulation device to help surgeons identify ureters during pelvic operations.
SATA Medical
This company develops reusable, articulating laparoscopic and robotic surgical instruments for hospitals and surgeons performing minimally invasive procedures.
ArgoMed
This company develops water-induced thermotherapy devices for the non-surgical treatment of benign prostatic hyperplasia in male patients.
